Comerica Bank
SRPT icon

Comerica Bank’s Sarepta Therapeutics SRPT Stock Holding History

Comerica Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$516K Sell
23,996
-761
-3% -$16K ﹤0.01% 1842
2025
Q3 		$477K Sell
24,757
-2,818
-10% -$50.2K ﹤0.01% 1912
2025
Q2 		$472K Buy
27,575
+257
+0.9% +$11K ﹤0.01% 1899
2025
Q1 		$1.74M Sell
27,318
-1,146
-4% -$121K 0.01% 1190
2024
Q4 		$3.46M Sell
28,464
-1,712
-6% -$210K 0.01% 865
2024
Q3 		$3.77M Sell
30,176
-4,031
-12% -$557K 0.01% 838
2024
Q2 		$5.4M Buy
34,207
+30,871
+925% +$3.97M 0.02% 636
2024
Q1 		$432K Buy
3,336
+2,770
+489% +$339K ﹤0.01% 1943
2023
Q4 		$54.6K Sell
566
-102,701
-99% -$9.85M ﹤0.01% 2692
2023
Q3 		$12.5M Buy
+103,267
New +$11.7M 0.07% 293
2022
Q4 		$10.7M Buy
82,228
+37,502
+84% +$4.35M 0.08% 256
2022
Q3 		$4.95M Buy
+44,726
New +$4.51M 0.04% 511
2021
Q1 		– Sell
-29,270
Closed -$2.88M – 2361
2020
Q4 		$2.88M Buy
29,270
+9,422
+47% +$1.4M 0.02% 1065
2020
Q3 		$2.73M Sell
19,848
-265
-1% -$40.3K 0.02% 909
2020
Q2 		$3.31M Sell
20,113
-3,618
-15% -$492K 0.03% 741
2020
Q1 		$2.88M Sell
23,731
-890
-4% -$102K 0.03% 698
2019
Q4 		$2.9M Sell
24,621
-1,350
-5% -$136K 0.02% 870
2019
Q3 		$2.17M Buy
25,971
+2,044
+9% +$241K 0.02% 1043
2019
Q2 		$3.69M Sell
23,927
-431
-2% -$52.4K 0.03% 686
2019
Q1 		$3.08M Sell
24,358
-575
-2% -$73.9K 0.03% 817
2018
Q4 		$2.89M Buy
24,933
+5,173
+26% +$647K 0.02% 835
2018
Q3 		$2.65M Buy
19,760
+3,386
+21% +$463K 0.02% 932
2018
Q2 		$2.25M Buy
16,374
+172
+1% +$16.2K 0.02% 1190
2018
Q1 		$1.27M Sell
16,202
-673
-4% -$44.9K 0.01% 1506
2017
Q4 		$1.11M Buy
+16,875
New +$894K 0.01% 1585

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Comerica Bank's SRPT Position: Q4 2025 in Review

Comerica Bank reduced its Sarepta Therapeutics (SRPT) stake by 3.1% in Q4 2025, selling an estimated $16K and leaving 23,996 shares worth $516K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

Comerica Bank first reported a position in SRPT in Q4 2017 and has held it in 25 quarters since. The position peaked at $12.5M in Q3 2023. 345 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Comerica Bank held 23,996 shares of Sarepta Therapeutics worth $516K as of Q4 2025.
  • Comerica Bank sold 761 Sarepta Therapeutics shares in Q4 2025, an estimated $16K.
  • Sarepta Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1842 holding.
  • Comerica Bank first reported a position in Sarepta Therapeutics in Q4 2017 and has held it in 25 quarters since.
  • Comerica Bank's Sarepta Therapeutics position peaked at $12.5M in Q3 2023.
  • 345 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.